Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century : an international comparison. / McKnight, J A; Wild, S H; Lamb, M J E; Cooper, M N; Jones, T W; Davis, E A; Hofer, S; Fritsch, M; Schober, E; Svensson, J; Almdal, T; Young, R; Warner, J T; Delemer, B; Souchon, P F; Holl, R W; Karges, W; Kieninger, D M; Tigas, S; Bargiota, A; Sampanis, C; Cherubini, V; Gesuita, R; Strele, I; Pildava, S; Coppell, K J; Magee, G; Cooper, J G; Dinneen, S F; Eeg-Olofsson, K; Svensson, A-M; Gudbjornsdottir, S; Veeze, H; Aanstoot, H-J; Khalangot, M; Tamborlane, W V; Miller, K M.
I: Diabetic Medicine, Bind 32, Nr. 8, 08.2015, s. 1036-50.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century
T2 - an international comparison
AU - McKnight, J A
AU - Wild, S H
AU - Lamb, M J E
AU - Cooper, M N
AU - Jones, T W
AU - Davis, E A
AU - Hofer, S
AU - Fritsch, M
AU - Schober, E
AU - Svensson, J
AU - Almdal, T
AU - Young, R
AU - Warner, J T
AU - Delemer, B
AU - Souchon, P F
AU - Holl, R W
AU - Karges, W
AU - Kieninger, D M
AU - Tigas, S
AU - Bargiota, A
AU - Sampanis, C
AU - Cherubini, V
AU - Gesuita, R
AU - Strele, I
AU - Pildava, S
AU - Coppell, K J
AU - Magee, G
AU - Cooper, J G
AU - Dinneen, S F
AU - Eeg-Olofsson, K
AU - Svensson, A-M
AU - Gudbjornsdottir, S
AU - Veeze, H
AU - Aanstoot, H-J
AU - Khalangot, M
AU - Tamborlane, W V
AU - Miller, K M
N1 - © 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.
PY - 2015/8
Y1 - 2015/8
N2 - AIMS: Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type 1 diabetes using data gathered in regional or national registries.METHODS: Data were obtained for children and/or adults with Type 1 diabetes from the following countries (or regions): Western Australia, Austria, Denmark, England, Champagne-Ardenne (France), Germany, Epirus, Thessaly and Thessaloniki (Greece), Galway (Ireland), several Italian regions, Latvia, Rotterdam (The Netherlands), Otago (New Zealand), Norway, Northern Ireland, Scotland, Sweden, Volyn (Ukraine), USA and Wales) from population or clinic-based registries. The sample size with available data varied from 355 to 173 880. Proportions with HbA1c < 58 mmol/mol (< 7.5%) and ≥ 75 mmol/mol (≥ 9.0%) were compared by age and sex.RESULTS: Data were available for 324 501 people. The proportions with HbA1c 58 mmol/mol (< 7.5%) varied from 15.7% to 46.4% among 44 058 people aged < 15 years, from 8.9% to 49.5% among 50 766 people aged 15-24 years and from 20.5% to 53.6% among 229 677 people aged ≥ 25 years. Sex differences in glycaemic control were small. Proportions of people using insulin pumps varied between the 12 sources with data available.CONCLUSION: These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults.
AB - AIMS: Improving glycaemic control in people with Type 1 diabetes is known to reduce complications. Our aim was to compare glycaemic control among people with Type 1 diabetes using data gathered in regional or national registries.METHODS: Data were obtained for children and/or adults with Type 1 diabetes from the following countries (or regions): Western Australia, Austria, Denmark, England, Champagne-Ardenne (France), Germany, Epirus, Thessaly and Thessaloniki (Greece), Galway (Ireland), several Italian regions, Latvia, Rotterdam (The Netherlands), Otago (New Zealand), Norway, Northern Ireland, Scotland, Sweden, Volyn (Ukraine), USA and Wales) from population or clinic-based registries. The sample size with available data varied from 355 to 173 880. Proportions with HbA1c < 58 mmol/mol (< 7.5%) and ≥ 75 mmol/mol (≥ 9.0%) were compared by age and sex.RESULTS: Data were available for 324 501 people. The proportions with HbA1c 58 mmol/mol (< 7.5%) varied from 15.7% to 46.4% among 44 058 people aged < 15 years, from 8.9% to 49.5% among 50 766 people aged 15-24 years and from 20.5% to 53.6% among 229 677 people aged ≥ 25 years. Sex differences in glycaemic control were small. Proportions of people using insulin pumps varied between the 12 sources with data available.CONCLUSION: These results suggest that there are substantial variations in glycaemic control among people with Type 1 diabetes between the data sources and that there is room for improvement in all populations, especially in young adults.
KW - Adolescent
KW - Adult
KW - Austria
KW - Denmark
KW - Diabetes Mellitus, Type 1
KW - England
KW - Female
KW - France
KW - Germany
KW - Greece
KW - Guideline Adherence
KW - Hemoglobin A, Glycosylated
KW - Humans
KW - Hypoglycemic Agents
KW - Insulin
KW - Insulin Infusion Systems
KW - Ireland
KW - Italy
KW - Latvia
KW - Male
KW - Netherlands
KW - New Zealand
KW - Northern Ireland
KW - Norway
KW - Practice Guidelines as Topic
KW - Registries
KW - Scotland
KW - Sweden
KW - Ukraine
KW - United States
KW - Wales
KW - Western Australia
KW - Young Adult
U2 - 10.1111/dme.12676
DO - 10.1111/dme.12676
M3 - Journal article
C2 - 25510978
VL - 32
SP - 1036
EP - 1050
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - 8
ER -
ID: 161696538